Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:38:33.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page header now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. No changes to study content or data are visible.
    Difference
    0.1%
    Check dated 2026-02-04T23:42:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary was added, and metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision/version updated to v3.4.0, replacing the previous v3.3.4 label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision was updated to v3.3.4, representing a minor metadata update that does not affect the study information shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:38.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations now includes New York; HHS Vulnerability Disclosure and New York Locations were removed. Page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:22:42.000Z thumbnail image

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.